(19)
(11) EP 1 272 240 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.06.2014 Bulletin 2014/23

(45) Mention of the grant of the patent:
30.04.2014 Bulletin 2014/18

(21) Application number: 01911998.1

(22) Date of filing: 20.03.2001
(51) International Patent Classification (IPC): 
A61M 5/50(2006.01)
A61M 5/32(2006.01)
 A61M 5/31(2006.01)
(86) International application number:
PCT/GB2001/001228
(87) International publication number:
WO 2001/072362 (04.10.2001 Gazette 2001/40)

(54)

HYPODERMIC SYRINGE

HYPODERMATISCHE SPRITZE

SERINGUE HYPODERMIQUE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 24.03.2000 GB 0007269

(43) Date of publication of application:
08.01.2003 Bulletin 2003/02

(73) Proprietor: C-Major Limited
Hughenden Valley, Buckinghamshire HP11 4PA (GB)

(72) Inventors:
  • Parker, David William
    Greenmount Bury Lancashire BL8 4QQ (GB)
  • Burgess, Colin Hamilton
    Ramsbottom lancashire BL0 9QR (GB)

(74) Representative: Boult Wade Tennant 
Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)


(56) References cited: : 
WO-A-94/07553
WO-A2-2004/030732
FR-A- 2 739 564
US-A- 5 779 677
 WO-A1-01/49347
FR-A- 2 739 563
US-A- 5 695 472
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).